BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

997 related articles for article (PubMed ID: 12888902)

  • 41. Simultaneously targeting epidermal growth factor receptor tyrosine kinase and cyclooxygenase-2, an efficient approach to inhibition of squamous cell carcinoma of the head and neck.
    Chen Z; Zhang X; Li M; Wang Z; Wieand HS; Grandis JR; Shin DM
    Clin Cancer Res; 2004 Sep; 10(17):5930-9. PubMed ID: 15355926
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lamin B, caspase-3 activity, and apoptosis induction by a combination of HMG-CoA reductase inhibitor and COX-2 inhibitors: a novel approach in developing effective chemopreventive regimens.
    Swamy MV; Cooma I; Reddy BS; Rao CV
    Int J Oncol; 2002 Apr; 20(4):753-9. PubMed ID: 11894121
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased cyclooxygenase-2 expression in human squamous cell carcinomas of the head and neck and inhibition of proliferation by nonsteroidal anti-inflammatory drugs.
    Lee DW; Sung MW; Park SW; Seong WJ; Roh JL; Park B; Heo DS; Kim KH
    Anticancer Res; 2002; 22(4):2089-96. PubMed ID: 12174888
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro and in vivo effects and mechanisms of celecoxib-induced growth inhibition of human hepatocellular carcinoma cells.
    Cui W; Yu CH; Hu KQ
    Clin Cancer Res; 2005 Nov; 11(22):8213-21. PubMed ID: 16299255
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of angiotensin II activity enhanced the antitumor effect of cyclooxygenase-2 inhibitors via insulin-like growth factor I receptor pathway.
    Yasumaru M; Tsuji S; Tsujii M; Irie T; Komori M; Kimura A; Nishida T; Kakiuchi Y; Kawai N; Murata H; Horimoto M; Sasaki Y; Hayashi N; Kawano S; Hori M
    Cancer Res; 2003 Oct; 63(20):6726-34. PubMed ID: 14583467
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2.
    Pyo H; Choy H; Amorino GP; Kim JS; Cao Q; Hercules SK; DuBois RN
    Clin Cancer Res; 2001 Oct; 7(10):2998-3005. PubMed ID: 11595687
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Celecoxib modulates the expression of cyclooxygenase-2, ki67, apoptosis-related marker, and microvessel density in human cervical cancer: a pilot study.
    Ferrandina G; Ranelletti FO; Legge F; Lauriola L; Salutari V; Gessi M; Testa AC; Werner U; Navarra P; Tringali G; Battaglia A; Scambia G
    Clin Cancer Res; 2003 Oct; 9(12):4324-31. PubMed ID: 14555502
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Enhancement of intrinsic tumor cell radiosensitivity induced by a selective cyclooxygenase-2 inhibitor.
    Petersen C; Petersen S; Milas L; Lang FF; Tofilon PJ
    Clin Cancer Res; 2000 Jun; 6(6):2513-20. PubMed ID: 10873107
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cyclooxygenase-2 promotes hepatocellular carcinoma cell growth through Akt activation: evidence for Akt inhibition in celecoxib-induced apoptosis.
    Leng J; Han C; Demetris AJ; Michalopoulos GK; Wu T
    Hepatology; 2003 Sep; 38(3):756-68. PubMed ID: 12939602
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Growth inhibition of breast epithelial cells by celecoxib is associated with upregulation of insulin-like growth factor binding protein-3 expression.
    Levitt RJ; Buckley J; Blouin MJ; Schaub B; Triche TJ; Pollak M
    Biochem Biophys Res Commun; 2004 Apr; 316(2):421-8. PubMed ID: 15020235
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synergistic tumoricidal effect between celecoxib and adenoviral-mediated delivery of mda-7 in human breast cancer cells.
    Suh YJ; Chada S; McKenzie T; Liu Y; Swisher SG; Lucci A; Hunt KK
    Surgery; 2005 Sep; 138(3):422-30. PubMed ID: 16213894
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CCAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction and ubiquitin/proteasome-mediated cellular FLICE-inhibitory protein down-regulation contribute to enhancement of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by dimethyl-celecoxib in human non small-cell lung cancer cells.
    Chen S; Liu X; Yue P; Schönthal AH; Khuri FR; Sun SY
    Mol Pharmacol; 2007 Nov; 72(5):1269-79. PubMed ID: 17684158
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enhancement of doxorubicin cytotoxicity on human esophageal squamous cell carcinoma cells by indomethacin and 4-[5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide (SC236) via inhibiting P-glycoprotein activity.
    Yu L; Wu WK; Li ZJ; Liu QC; Li HT; Wu YC; Cho CH
    Mol Pharmacol; 2009 Jun; 75(6):1364-73. PubMed ID: 19264847
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A selective cyclooxygenase-2 inhibitor, NS398, inhibits cell growth and induces cell cycle arrest in the G2/M phase in human esophageal squamous cell carcinoma cells.
    Kase S; Osaki M; Honjo S; Takeda A; Adachi K; Araki K; Ito H
    J Exp Clin Cancer Res; 2004 Jun; 23(2):301-7. PubMed ID: 15354416
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Influence of selective cyclooxygenase-2 inhibitor on proliferation of human gastric cancer cells].
    Li JY; Yu JP; Luo HS; Yu BP; Tian G; Mei Q; Huang JA
    Ai Zheng; 2002 Jun; 21(6):625-9. PubMed ID: 12452063
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increased expression of cyclooxygenase (COX)-2 in DMBA-induced hamster cheek pouch carcinogenesis and chemopreventive effect of a selective COX-2 inhibitor celecoxib.
    Nishimura N; Urade M; Hashitani S; Noguchi K; Manno Y; Takaoka K; Sakurai K
    J Oral Pathol Med; 2004 Nov; 33(10):614-21. PubMed ID: 15482328
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: growth inhibition by nonsteroidal anti-inflammatory drugs.
    Molina MA; Sitja-Arnau M; Lemoine MG; Frazier ML; Sinicrope FA
    Cancer Res; 1999 Sep; 59(17):4356-62. PubMed ID: 10485483
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Selective COX-2 inhibitor regulates the MAP kinase signaling pathway in human osteoarthritic chondrocytes after induction of nitric oxide.
    Takahashi T; Ogawa Y; Kitaoka K; Tani T; Uemura Y; Taguchi H; Kobayashi T; Seguchi H; Yamamoto H; Yoshida S
    Int J Mol Med; 2005 Feb; 15(2):213-9. PubMed ID: 15647833
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of p53 or p27 overexpression on cyclooxygenase-2 gene expression in head and neck squamous cell carcinoma cell lines.
    Lee DW; Park SW; Park SY; Heo DS; Kim KH; Sung MW
    Head Neck; 2004 Aug; 26(8):706-15. PubMed ID: 15287038
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Celecoxib induced tumor cell radiosensitization by inhibiting radiation induced nuclear EGFR transport and DNA-repair: a COX-2 independent mechanism.
    Dittmann KH; Mayer C; Ohneseit PA; Raju U; Andratschke NH; Milas L; Rodemann HP
    Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):203-12. PubMed ID: 17996386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 50.